Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type II Non-Obese Diabetic”

26 trials

Showing 20 of 26 results

Testing effectiveness (Phase 2)Study completedNCT02313220
What this trial is testing

Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight

Who this might be right for
Obesity
Uppsala University 50
Testing effectiveness (Phase 2)Study completedNCT00478322
What this trial is testing

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Incyte Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00042601
What this trial is testing

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
AstraZeneca 51
Not applicableStudy completedNCT02028975
What this trial is testing

Search for Biological Markers of Orosensory Perception of Fatty Acids in Healthy Subjects and Possible Modifications in Patients With Type 2 Diabetes and in Obese Non-diabetic Patients.

Who this might be right for
Type 2 Diabetes or Obesity Without Diabetes
Centre Hospitalier Universitaire Dijon 81
Testing effectiveness (Phase 2)Study completedNCT00156897
What this trial is testing

Efficacy and Safety of ATL-962 in Obese Diabetics

Who this might be right for
Non-Insulin-Dependent Diabetes MellitusObesity
Alizyme 600
Not applicableUnknownNCT02091323
What this trial is testing

Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Guangzhou General Hospital of Guangzhou Military Command 200
Post-approval studies (Phase 4)Study completedNCT00339833
What this trial is testing

The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers

Who this might be right for
Type 2 DiabetesDiabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 54
Testing effectiveness (Phase 2)Ended earlyNCT01842282
What this trial is testing

Amlexanox for Type 2 Diabetes and Obesity

Who this might be right for
Diabetes Mellitus Type 2Non Alcoholic Fatty Liver DiseaseObesity
University of Michigan 7
Large-scale testing (Phase 3)Ended earlyNCT00449605
What this trial is testing

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 508
Testing effectiveness (Phase 2)Study completedNCT04617275
What this trial is testing

A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY

Who this might be right for
DiabetesObesity
Pfizer 151
Testing effectiveness (Phase 2)Study completedNCT00566358
What this trial is testing

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

Who this might be right for
Diabetes Mellitus, Type 2
University of Campinas, Brazil 18
Testing effectiveness (Phase 2)Study completedNCT01975935
What this trial is testing

Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus Type 2Non-alcoholic Fatty Liver DiseaseObesity
University of Michigan 42
Early research (Phase 1)Study completedNCT03414736
What this trial is testing

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 60
Not applicableStudy completedNCT00704314
What this trial is testing

Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients?

Who this might be right for
HypercholesterolemiaDiabetesCardiovascular Disease
Medical University of Vienna 20
Not applicableActive Not RecruitingNCT01047735
What this trial is testing

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Pittsburgh 69
Not applicableStudy completedNCT02332993
What this trial is testing

Nutritional Regulation of Wound Inflammation: Part III

Who this might be right for
Negative Pressure TherapyWoundOpen Wound+2 more
Ohio State University 22
Not applicableUnknownNCT04081064
What this trial is testing

Impact of Body Composition and Exercise on Clinical, Metabolic and Molecular Parameters in Type 2 Diabetics in Qatar

Who this might be right for
Type 2 Diabetes
Hamad Medical Corporation 60
Not applicableStudy completedNCT00849342
What this trial is testing

Observational Study on Levemir® in Obese Diabetic Patients

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 580
Early research (Phase 1)Study completedNCT04407234
What this trial is testing

Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

Who this might be right for
OverweightObesityDiabetes Mellitus, Type 2
Eli Lilly and Company 36
Not applicableStudy completedNCT01141192
What this trial is testing

The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

Who this might be right for
Type 2 Diabetes
Augusta University 48
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation